» Articles » PMID: 31062473

Down-regulation of TFAM Increases the Sensitivity of Tumour Cells to Radiation Via P53/TIGAR Signalling Pathway

Overview
Journal J Cell Mol Med
Date 2019 May 8
PMID 31062473
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial transcription factor A (TFAM) is a key regulator of mitochondria biogenesis. Previous studies confirmed that reduced TFAM expression sensitized tumours cells to chemical therapy reagents and ionizing irradiation (IR). However, the underlying mechanisms remain largely unknown. In this study, we identified that decreased expression of TFAM impaired the proliferation of tumour cells by inducing G1/S phase arrest and reducing the expression of E2F1, phospo-Rb, PCNA and TK1. Furthermore, we proved that knockdown of TFAM enhanced the interaction between p53 and MDM2, resulting in decreased expression of p53 and the downstream target TIGAR, and thus leading to elevated level of mitochondrial superoxide and DNA double-strand break (DSB) which were exacerbated when treated the cell with ionizing radiation. Those indicated that knockdown of TFAM could aggravate radiation induced DSB levels through affecting the production of mitochondria derived reactive oxygen species. Our current work proposed a new mechanism that TFAM through p53/TIGAR signalling to regulate the sensitivity of tumour cells to ionizing radiation. This indicated that TFAM might be a potential target for increasing the sensitization of cancer cells to radiotherapy.

Citing Articles

TEFM facilitates uterine corpus endometrial carcinoma progression by activating ROS-NFκB pathway.

Lei J, Zhu Q, Guo J, Chen J, Qi L, Cui M J Transl Med. 2024; 22(1):1151.

PMID: 39731053 PMC: 11673371. DOI: 10.1186/s12967-024-05833-0.


Environmental endocrine disruptor-induced mitochondrial dysfunction: a potential mechanism underlying diabetes and its complications.

He K, Chen R, Xu S, Ding Y, Wu Z, Bao M Front Endocrinol (Lausanne). 2024; 15:1422752.

PMID: 39211449 PMC: 11357934. DOI: 10.3389/fendo.2024.1422752.


Mitochondria transcription and cancer.

Lei T, Rui Y, Xiaoshuang Z, Jinglan Z, Jihong Z Cell Death Discov. 2024; 10(1):168.

PMID: 38589371 PMC: 11001877. DOI: 10.1038/s41420-024-01926-3.


Zinc finger protein 468 up-regulation of TFAM contributes to the malignant growth and cisplatin resistance of breast cancer cells.

Jia Z, Wang F, Li G, Jiang P, Leng Y, Ke L Cell Div. 2024; 19(1):8.

PMID: 38429817 PMC: 10908137. DOI: 10.1186/s13008-024-00113-1.


Mitochondrial DNA-targeted therapy: A novel approach to combat cancer.

Lin Y, Yang B, Huang Y, Zhang Y, Jiang Y, Ma L Cell Insight. 2023; 2(4):100113.

PMID: 37554301 PMC: 10404627. DOI: 10.1016/j.cellin.2023.100113.


References
1.
Ahmad F, Ghosh S, Sinha S, Joshi S, Mehta V, Sen E . TGF-β-induced hCG-β regulates redox homeostasis in glioma cells. Mol Cell Biochem. 2014; 399(1-2):105-12. DOI: 10.1007/s11010-014-2237-6. View

2.
Lebedeva M, Eaton J, Shadel G . Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis. Biochim Biophys Acta. 2009; 1787(5):328-34. PMC: 2680458. DOI: 10.1016/j.bbabio.2009.01.004. View

3.
Lee H, Chang C, Chi C . Somatic mutations of mitochondrial DNA in aging and cancer progression. Ageing Res Rev. 2010; 9 Suppl 1:S47-58. DOI: 10.1016/j.arr.2010.08.009. View

4.
Finkel T . Redox-dependent signal transduction. FEBS Lett. 2000; 476(1-2):52-4. DOI: 10.1016/s0014-5793(00)01669-0. View

5.
Vousden K, Prives C . Blinded by the Light: The Growing Complexity of p53. Cell. 2009; 137(3):413-31. DOI: 10.1016/j.cell.2009.04.037. View